Montag, 29. April 2024
Navigation öffnen
Anzeige:
Wefra Programatic
 
JOURNAL ONKOLOGIE – STUDIE
TRANSFORM-2

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

Rekrutierend

NCT-Nummer:
NCT04468984

Studienbeginn:
August 2020

Letztes Update:
04.04.2024

Wirkstoff:
Navitoclax, Ruxolitinib, Best Available Therapy (BAT)

Indikation (Clinical Trials):
Primary Myelofibrosis

Geschlecht:
Alle

Altersgruppe:
Erwachsene (18+)

Phase:
Phase 3

Sponsor:
AbbVie

Collaborator:
-

Studienleiter

ABBVIE INC.
Study Director
AbbVie

Kontakt

Studienlocations
(3 von 215)

Universitatsklinikum Mannheim /ID# 221529
68167 Mannheim
(Baden-Württemberg)
GermanyRekrutierend» Google-Maps
Stauferklinikum Schwaebisch Gmuend /ID# 223948
73557 Mutlangen
(Baden-Württemberg)
GermanyRekrutierend» Google-Maps
Gemeinschaftspraxis Dr. Heinrich und Prof. Bangerter /ID# 225025
86150 Augsburg
(Bayern)
GermanyAbgeschlossen» Google-Maps
BAG Freiberg-Richter, Jacobasch, Illmer, Wolf /ID# 221346
01307 Dresden
(Sachsen)
GermanyRekrutierend» Google-Maps
Augusta-Kranken-Anstalt gGmbH, Bochum-Mitte /ID# 224695
44791 Bochum
(Nordrhein-Westfalen)
GermanyAbgeschlossen» Google-Maps
Klinikum Chemnitz gGmbH /ID# 224575
09116 Chemnitz
(Sachsen)
GermanyRekrutierend» Google-Maps
OncoResearch Lerchenfeld GmbH /ID# 225034
22081 Hamburg
(Hamburg)
GermanyAbgeschlossen» Google-Maps
Klinikum rechts der Isar /ID# 221526
81675 Munich
(Bayern)
GermanyRekrutierend» Google-Maps
Universitaetsmedizin Rostock /ID# 224157
18057 Rostock
(Mecklenburg-Vorpommern)
GermanyRekrutierend» Google-Maps
Ironwood Cancer & Res Ctr /ID# 222162
85224-5665 Chandler
United StatesAbgeschlossen» Google-Maps
Highlands Oncology Group, PA /ID# 221826
72762 Springdale
United StatesRekrutierend» Google-Maps
Moores Cancer Center at UC San Diego /ID# 219009
92093 La Jolla
United StatesAbgeschlossen» Google-Maps
Long Beach Memorial Medical Ct /ID# 224542
90806-1701 Long Beach
United StatesRekrutierend» Google-Maps
St. Mary's Hospital Regional Cancer Center /ID# 224229
81501-6132 Grand Junction
United StatesRekrutierend» Google-Maps
Columbus Regional Research Institute /ID# 224410
31904-8915 Columbus
United StatesAbgeschlossen» Google-Maps
Northwest Oncology & Hematology - Elk Grove Village /ID# 222818
60007-3361 Elk Grove Village
United StatesRekrutierend» Google-Maps
Loyola University Medical Ctr /ID# 219048
60153 Maywood
United StatesRekrutierend» Google-Maps
Indiana Blood & Marrow Transpl /ID# 221587
46237 Indianapolis
United StatesRekrutierend» Google-Maps
Tulane Medical Center - New Orleans /ID# 222940
70112-2600 New Orleans
United StatesAbgeschlossen» Google-Maps
Ochsner Clinic Foundation-New Orleans /ID# 222777
70121 New Orleans
United StatesAbgeschlossen» Google-Maps
American Oncology Partners of Maryland, PA /ID# 222836
20817 Bethesda
United StatesRekrutierend» Google-Maps
Henry Ford Health System /ID# 221190
48202 Detroit
United StatesRekrutierend» Google-Maps
William Beaumont Hospital /ID# 222705
48073-6710 Royal Oak
United StatesRekrutierend» Google-Maps
Saint Louis University Cancer Center /ID# 222287
63110-2539 Saint Louis
United StatesRekrutierend» Google-Maps
Summit Medical Group-Florham Park /ID# 222620
07932-1049 Florham Park
United StatesRekrutierend» Google-Maps
The Cancer Institute at St. Francis Hospital /ID# 231782
11548-1219 Greenvale
United StatesRekrutierend» Google-Maps
Manhattan Hematology Oncology MHO Associates /ID# 223193
10016-6028 New York
United StatesRekrutierend» Google-Maps
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 221081
10065-6007 New York
United StatesRekrutierend» Google-Maps
Wake Forest Baptist Medical Center /ID# 222899
27157-0001 Winston-Salem
United StatesRekrutierend» Google-Maps
MetroHealth Medical Center /ID# 222650
44109 Cleveland
United StatesRekrutierend» Google-Maps
Fox Chase Cancer Center /ID# 223955
19111 Philadelphia
United StatesAbgeschlossen» Google-Maps
Houston Methodist Hospital /ID# 223103
77030 Houston
United StatesAbgeschlossen» Google-Maps
University of Texas Health San Antonio MD Anderson Cancer Center /ID# 233942
78229 San Antonio
United StatesAbgeschlossen» Google-Maps
Utah Cancer Specialists Salt Lake Clinic /ID# 221962
84106 Salt Lake City
United StatesRekrutierend» Google-Maps
Virginia Cancer Specialists - Fairfax /ID# 223016
22031 Fairfax
United StatesRekrutierend» Google-Maps
Providence Everett /ID# 223130
98201 Everett
United StatesAbgeschlossen» Google-Maps
Yakima Valley Memorial Hosp /ID# 224368
98902-6388 Yakima
United StatesRekrutierend» Google-Maps
HSHS St. Vincent Hospital /ID# 224468
54301 Green Bay
United StatesRekrutierend» Google-Maps
The Kinghorn Cancer Centre /ID# 221097
2010 Darlinghurst
AustraliaRekrutierend» Google-Maps
Border Medical Oncology Research Unit Albury Wodonga Regiona /ID# 223848
2640 East Albury
AustraliaRekrutierend» Google-Maps
Calvary Mater Newcastle /ID# 224324
2298 Waratah
AustraliaRekrutierend» Google-Maps
Alfred Health /ID# 221096
3004 Melbourne
AustraliaRekrutierend» Google-Maps
Royal Perth Hospital /ID# 221099
6000 Perth
AustraliaRekrutierend» Google-Maps
Universitaetsklinikum St. Poelten /ID# 221709
3100 Sankt Poelten
AustriaRekrutierend» Google-Maps
Ordensklinikum Linz GmbH Elisabethinen /ID# 220914
4010 Linz
AustriaRekrutierend» Google-Maps
Klinikum Wels-Grieskirchen GmbH /ID# 220915
4600 Wels
AustriaRekrutierend» Google-Maps
Medizinische Universitaet Graz /ID# 220919
8010 Graz
AustriaRekrutierend» Google-Maps
Medizinische Universitaet Wien /ID# 220911
1090 Vienna
AustriaAbgeschlossen» Google-Maps
UCL Saint-Luc /ID# 224221
1200 Woluwe-Saint-Lambert
BelgiumAbgeschlossen» Google-Maps
Grand Hopital de Charleroi /ID# 224827
6000 Charleroi
BelgiumRekrutierend» Google-Maps
UMHAT Alexandrovska EAD /ID# 231652
1431 Sofiya
BulgariaRekrutierend» Google-Maps
UMHAT Dr Georgi Stranski EAD /ID# 231650
5800 Pleven
BulgariaRekrutierend» Google-Maps
Acibadem City Clinic Tokuda University Hospital EAD /ID# 231649
1407 Sofia
BulgariaRekrutierend» Google-Maps
UMHAT Sveti Ivan Rilski /ID# 231651
1431 Sofia
BulgariaRekrutierend» Google-Maps
UMHAT Sveta Marina /ID# 234119
9010 Varna
BulgariaRekrutierend» Google-Maps
Juravinski Cancer Centre /ID# 220887
L8V 1C3 Hamilton
CanadaRekrutierend» Google-Maps
Ottawa Hospital Research Institute /ID# 238858
K1H 8L6 Ottawa
CanadaRekrutierend» Google-Maps
Princess Margaret Cancer Centre /ID# 253942
M5G 2M9 Toronto
CanadaRekrutierend» Google-Maps
CISSS-CA (Centre Integre de sante et de services sociaux de Chaudiere-Appalache) /ID# 222433
G6V 3Z1 Levis
CanadaRekrutierend» Google-Maps
Ansprechpartner:
Site Coordinator
Phone: 14188307474
» Ansprechpartner anzeigen
McGill University Health Center Research Institute /ID# 222614
H4A 3J1 Montreal
CanadaRekrutierend» Google-Maps
Clinical Hospital Dubrava /ID# 230801
10000 Zagreb
CroatiaRekrutierend» Google-Maps
Klinicka bolnica Merkur /ID# 230799
10000 Zagreb
CroatiaRekrutierend» Google-Maps
Klinicki bolnicki centar Zagreb /ID# 230798
10000 Zagreb
CroatiaAktiv, nicht rekrutierend» Google-Maps
Klinicki Bolnicki Centar (KBC) Split - Firule /ID# 230800
21000 Split
CroatiaRekrutierend» Google-Maps
Klinicki bolnicki centar Osijek /ID# 231503
31000 Osijek
CroatiaRekrutierend» Google-Maps
Fakultni nemocnice Brno /ID# 220959
613 00 Brno
CzechiaRekrutierend» Google-Maps
Vseobecna fakultni nemocnice v Praze /ID# 220969
128 08 Praha
CzechiaAbgeschlossen» Google-Maps
Aalborg University Hospital /ID# 224391
9000 Aalborg
DenmarkRekrutierend» Google-Maps
Roskilde Sygehus /ID# 224456
4000 Roskilde
DenmarkRekrutierend» Google-Maps
Chu de Nice-Hopital L'Archet Ii /Id# 256291
06200 Nice
FranceRekrutierend» Google-Maps
CHU NIMES - Hopital Caremeau /ID# 219128
30029 Nimes CEDEX 9
FranceRekrutierend» Google-Maps
CHU Bordeaux - Hopital Haut Leveque /ID# 222696
33604 Pessac
FranceRekrutierend» Google-Maps
Hopital Avicenne - APHP /ID# 221287
93000 Bobigny
FranceAbgeschlossen» Google-Maps
CHU de Nantes, Hotel Dieu -HME /ID# 219127
44000 Nantes
FranceAbgeschlossen» Google-Maps
HCL - Hopital Lyon Sud /ID# 222695
69495 Pierre Benite CEDEX
FranceRekrutierend» Google-Maps
Centre Hospitalier de CHAMBERY /ID# 223771
73000 Chambery
FranceRekrutierend» Google-Maps
AP-HP - Hopital Saint-Louis /ID# 221390
75010 Paris
FranceRekrutierend» Google-Maps
General Hospital of Athens Laiko /ID# 221175
11527 Athens
GreeceRekrutierend» Google-Maps
General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 221179
10676 Athens
GreeceRekrutierend» Google-Maps
Olympion General Clinic SA /ID# 261423
26443 Patras
GreeceRekrutierend» Google-Maps
University General Hospital of Patras /ID# 221178
26504 RION Patras Achaia
GreeceAbgeschlossen» Google-Maps
General Hospital of Thessaloniki George Papanikolaou /ID# 221463
57010 Thessaloniki
GreeceRekrutierend» Google-Maps
Szegedi Tudomanyegyetem /ID# 220955
6720 Szeged
HungaryRekrutierend» Google-Maps
Fejér Vármegyei Szent György Egyetemi Oktató Kórház /ID# 220949
8000 Szekesfehervar
HungaryRekrutierend» Google-Maps
Debreceni Egyetem Klinikai Kozpont /ID# 220947
4032 Debrecen
HungaryRekrutierend» Google-Maps
Somogy Varmegyei Kaposi Mor Oktato Korhaz /ID# 220948
7400 Kaposvár
HungaryAbgeschlossen» Google-Maps
Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz /ID# 220946
4400 Nyiregyhaza
HungaryRekrutierend» Google-Maps
Rambam Health Care Campus /ID# 219121
3109601 Haifa
IsraelAbgeschlossen» Google-Maps
The Lady Davis Carmel Medical Center /ID# 222973
34362 Haifa
IsraelRekrutierend» Google-Maps
Rabin Medical Center /ID# 219139
4941492 Haifa
IsraelRekrutierend» Google-Maps
Assuta Ashdod Medical Center /ID# 225281
7747629 Ashdod
IsraelRekrutierend» Google-Maps
Assaf Harofeh Medical Center /ID# 222972
70300 Zerifin
IsraelRekrutierend» Google-Maps
Galilee Medical Center /ID# 225280
2210001 Nahariya
IsraelRekrutierend» Google-Maps
The Chaim Sheba Medical Center /ID# 219136
5265601 Ramat Gan
IsraelRekrutierend» Google-Maps
Tel Aviv Sourasky Medical Center /ID# 219135
6423906 Tel Aviv
IsraelRekrutierend» Google-Maps
Hadassah Medical Center-Hebrew University /ID# 219111
91120 Jerusalem
IsraelRekrutierend» Google-Maps
Hadassah Mt. Scopus /ID# 253394
9765400 Jerusalem
IsraelRekrutierend» Google-Maps
Clalit Health Services - Emek Medical Center /ID# 220839
1834111 Afula
IsraelRekrutierend» Google-Maps
Azienda Ospedaliero Universitaria Ospedali Riuniti Do Ancona /ID# 238438
60020 Torette
ItalyRekrutierend» Google-Maps
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Università Cattolica /ID# 219087
00168 Rome
ItalyRekrutierend» Google-Maps
ASST Monza/Ospedale San Gerardo /ID# 225113
20900 Monza
ItalyRekrutierend» Google-Maps
AOU Citta della Salute e della Scienza di Torino /ID# 221223
10126 Torino
ItalyRekrutierend» Google-Maps
Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 225731
00161 Rome
ItalyRekrutierend» Google-Maps
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Presidio Papa Giovanni /ID# 221222
24127 Bergamo
ItalyRekrutierend» Google-Maps
IRCCS Azienda Ospedaliero-Universitaria di Bologna /ID# 221077
40138 Bologna
ItalyRekrutierend» Google-Maps
A.O.U. Policlinico G. Rodolico S.Marco- Presidio G.Rodolico /ID# 219089
95123 Catania
ItalyRekrutierend» Google-Maps
Azienda Ospedaliero Universitaria Careggi /ID# 219090
50134 Florence
ItalyRekrutierend» Google-Maps
Azienda Ospedaliera Universitaria Federico II /ID# 224673
80131 Napoli
ItalyRekrutierend» Google-Maps
Azienda Ospedaliera Universitaria Paolo Giaccone /ID# 221078
90127 Palermo
ItalyRekrutierend» Google-Maps
Grande Ospedale Metropolitano Bianchi Melacrino Morelli /ID# 221220
89124 Reggio Calabria
ItalyRekrutierend» Google-Maps
Azienda Ospedaliera Universitaria Friuli Centrale/Presidio Ospedaliero Universit /ID# 221241
33100 Udine
ItalyRekrutierend» Google-Maps
Azienda ULSS 8 Berica/Ospedale San Bortolo di Vicenza /ID# 221079
36100 Vicenza
ItalyRekrutierend» Google-Maps
Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital /ID# 221150
453-8511 Nagoya-shi
JapanRekrutierend» Google-Maps
Fujita Health University /ID# 221598
470-1192 Toyoake
JapanRekrutierend» Google-Maps
Aomori Prefectural Central Hospital /ID# 221778
030-8553 Aomori-shi
JapanRekrutierend» Google-Maps
Chiba University Hospital /ID# 224546
260-8677 Chiba-shi
JapanRekrutierend» Google-Maps
National Cancer Center Hospital East /ID# 226653
277-8577 Kashiwa-shi
JapanRekrutierend» Google-Maps
Ehime University Hospital /ID# 221158
791-0295 Toon-shi
JapanRekrutierend» Google-Maps
Kyushu University Hospital /ID# 221606
812-8582 Fukuoka-shi
JapanRekrutierend» Google-Maps
Fukushima Medical University Hospital /ID# 221877
960-1295 Fukushima-shi
JapanRekrutierend» Google-Maps
Gifu University Hospital /ID# 224371
501-1194 Gifu-shi
JapanRekrutierend» Google-Maps
Sapporo Hokuyu Hospital /ID# 221149
003-0006 Sapporo-shi
JapanRekrutierend» Google-Maps
Kobe City Medical Center General Hospital /ID# 221156
650-0047 Kobe-shi
JapanRekrutierend» Google-Maps
Kanazawa University Hospital /ID# 223028
920-8641 Kanazawa-shi
JapanRekrutierend» Google-Maps
Iwate Medical University Hospital /ID# 222044
028-3695 Shiwa-gun
JapanRekrutierend» Google-Maps
Shonan Kamakura General Hospital /ID# 223030
247-8533 Kamakura-shi
JapanRekrutierend» Google-Maps
Kumamoto Shinto General Hospital /ID# 255645
862-8655 Kumamoto-shi
JapanRekrutierend» Google-Maps
Kyoto University Hospital /ID# 223008
606-8507 Kyoto-shi
JapanRekrutierend» Google-Maps
Mie University Hospital /ID# 221665
514-8507 Tsu-shi
JapanRekrutierend» Google-Maps
University of Miyazaki Hospital /ID# 221821
889-1692 Miyazaki-shi
JapanRekrutierend» Google-Maps
Niigata University Medical & Dental Hospital /ID# 223034
951-8520 Niigata-shi
JapanRekrutierend» Google-Maps
Kurashiki Central Hospital /ID# 221690
710-8602 Kurashiki-shi
JapanRekrutierend» Google-Maps
Osaka University Hospital /ID# 221159
565-0871 Suita-shi
JapanRekrutierend» Google-Maps
Dokkyo Medical University Saitama Medical Center /ID# 222334
343-8555 Koshigaya-shi
JapanRekrutierend» Google-Maps
Juntendo University Shizuoka Hospital /ID# 221780
410-2295 Izunokuni-shi
JapanRekrutierend» Google-Maps
Juntendo University Hospital /ID# 221154
113-8431 Bunkyo-ku
JapanRekrutierend» Google-Maps
Nippon Medical School Hospital /ID# 221676
113-8602 Bunkyo-ku
JapanRekrutierend» Google-Maps
The Institute of Medical Science the University of Tokyo Hospital /ID# 257944
108-8639 Minato-ku
JapanRekrutierend» Google-Maps
Tokyo Medical University Hospital /ID# 221540
160-0023 Shinjuku-ku
JapanRekrutierend» Google-Maps
Tokyo Metropolitan Bokutoh Hospital /ID# 254774
130-8575 Sumida-ku
JapanRekrutierend» Google-Maps
University of Yamanashi Hospital /ID# 221706
409-3821 Chuo-shi
JapanRekrutierend» Google-Maps
The Catholic University of Korea, Seoul St. Marys Hospital /ID# 219061
06591 Seoul
Korea, Republic ofRekrutierend» Google-Maps
Pusan National University Hospital /ID# 220980
49241 Busan
Korea, Republic ofRekrutierend» Google-Maps
Gachon University Gil Medical Center /ID# 220972
21565 Incheon
Korea, Republic ofRekrutierend» Google-Maps
Seoul National University Hospital /ID# 219060
03080 Seoul
Korea, Republic ofRekrutierend» Google-Maps
Samsung Medical Center /ID# 221091
06351 Seoul
Korea, Republic ofRekrutierend» Google-Maps
Aotearoa Clinical Trials /ID# 232201
2025 Papatoetoe
New ZealandRekrutierend» Google-Maps
Wojewodzkie Wielospecjalistyczne Centrum Onkologii I Traumatologii Im. M. Kopern /Id# 221161
93-513 Lodz
PolandRekrutierend» Google-Maps
Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie /ID# 221124
20-081 Lublin
PolandRekrutierend» Google-Maps
SP ZOZ Szpital Uniwersytecki w Krakowie /ID# 221160
31-501 Krakow
PolandAbgeschlossen» Google-Maps
Lux Med Onkologia - Szpital Szamocka /Id# 221265
01-748 Warszawa
PolandAbgeschlossen» Google-Maps
MTZ Clinical Research Powered by Pratia /ID# 221759
02-172 Warszawa
PolandRekrutierend» Google-Maps
Uniwersyteckie Centrum Kliniczne /ID# 221298
80-214 Gdansk
PolandRekrutierend» Google-Maps
ARS-MEDICAL Sp. z o.o. /ID# 238336
64-920 Pila
PolandRekrutierend» Google-Maps
Szpital Kliniczny im. Heliodora Swiecickiego Uniwersytetu Medycznego im. Karola /ID# 241031
60-569 Poznan
PolandRekrutierend» Google-Maps
Pratia Onkologia Katowice /ID# 224526
40-519 Katowice
PolandAbgeschlossen» Google-Maps
Hospital del Centro Comprensivo de Cancer de la UPR /ID# 223281
00927 San Juan
Puerto RicoRekrutierend» Google-Maps
Moscow State budget healthcare /ID# 221116
125284 Moscow
Russian FederationAktiv, nicht rekrutierend» Google-Maps
Hospital n.a. V.V. Veresaev /ID# 225221
127644 Moscow
Russian FederationAbgeschlossen» Google-Maps
Russian Research Institute of Hematology and Transfusiology of the FMBA /ID# 221115
191024 Sankt-Peterburg
Russian FederationAktiv, nicht rekrutierend» Google-Maps
Almazov National Medical Research Centre /ID# 221114
197341 Sankt-Peterburg
Russian FederationAktiv, nicht rekrutierend» Google-Maps
Tula Regional Clinical Hospital /ID# 221302
300053 Tula
Russian FederationAbgeschlossen» Google-Maps
University Clinical Center Serbia /ID# 231058
11000 Belgrade
SerbiaRekrutierend» Google-Maps
Clin Hosp Ctr Bezanijska Kosa /ID# 231059
11080 Belgrade
SerbiaRekrutierend» Google-Maps
Clinical Center Vojvodina /ID# 231057
21000 Novi Sad
SerbiaRekrutierend» Google-Maps
Wits Clinical Research Site /ID# 231554
2193 Johannesburg
South AfricaAbgeschlossen» Google-Maps
Alberts Cellular Therapy /ID# 231556
0044 Pretoria
South AfricaRekrutierend» Google-Maps
Hospital Clínico Universitario de Santiago-CHUS /ID# 221616
15706 Santiago de Compostela
SpainRekrutierend» Google-Maps
Hospital Universitario Central de Asturias /ID# 224815
33011 Oviedo
SpainRekrutierend» Google-Maps
Hospital Universitario Germans Trias i Pujol /ID# 233727
08916 Badalona
SpainRekrutierend» Google-Maps
Hospital Universitario Dr. Negrin /ID# 220923
35019 Las Palmas de Gran Canaria
SpainRekrutierend» Google-Maps
Hospital Universitario A Coruna - CHUAC /ID# 224617
15006 A Coruna
SpainRekrutierend» Google-Maps
Hospital Parc de Salut del Mar /ID# 220922
08003 Barcelona
SpainRekrutierend» Google-Maps
Hospital Universitario Vall d'Hebron /ID# 240979
08035 Barcelona
SpainRekrutierend» Google-Maps
Hospital Universitario Virgen de las Nieves /ID# 253936
18014 Granada
SpainRekrutierend» Google-Maps
Hospital Universitario 12 de Octubre /ID# 233726
28041 Madrid
SpainRekrutierend» Google-Maps
Hospital Universitario La Paz /ID# 224813
28046 Madrid
SpainRekrutierend» Google-Maps
Hospital Regional Universitario de Malaga /ID# 221906
29011 Malaga
SpainAbgeschlossen» Google-Maps
Hospital Universitario de Salamanca /ID# 221904
37711 Salamanca
SpainAbgeschlossen» Google-Maps
Hospital Universitario Virgen del Rocio /ID# 221932
41013 Sevilla
SpainRekrutierend» Google-Maps
Hospital Clinico Universitario de Valencia /ID# 220920
46010 Valencia
SpainRekrutierend» Google-Maps
Skane University Hospital Lund /ID# 220834
224 84 Lund
SwedenRekrutierend» Google-Maps
Universitätsspital Basel /ID# 221261
4031 Basel
SwitzerlandAbgeschlossen» Google-Maps
Inselspital, Universitaetsspital Bern /ID# 223439
3010 Bern
SwitzerlandAbgeschlossen» Google-Maps
Kaohsiung Chang Gung Memorial Hospital /ID# 218985
833 Kaohsiung City
TaiwanRekrutierend» Google-Maps
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 218980
807 Kaohsiung
TaiwanAbgeschlossen» Google-Maps
China Medical University Hospital /ID# 218979
40447 Taichung
TaiwanRekrutierend» Google-Maps
Chi Mei Hospital - Liouying /ID# 221144
73657 Tainan City
TaiwanRekrutierend» Google-Maps
Taipei Veterans General Hosp /ID# 221147
11217 Taipei
TaiwanRekrutierend» Google-Maps
Linkou Chang Gung Memorial Hospital /ID# 218982
333 Taoyuan City
TaiwanRekrutierend» Google-Maps
Gulhane Askeri Tip Academy /ID# 224568
06010 Ankara
TurkeyAbgeschlossen» Google-Maps
Trakya University Medical Facu /ID# 224572
22030 Edirne, Istanbul
TurkeyRekrutierend» Google-Maps
Ege University Medical Faculty /ID# 224570
35040 Izmir
TurkeyRekrutierend» Google-Maps
Mersin University Medical /ID# 224571
33343 Mersin
TurkeyRekrutierend» Google-Maps
Ondokuz mayis University Facul /ID# 224567
55200 Samsun
TurkeyRekrutierend» Google-Maps
United Lincolnshire Hospitals NHS Trust /ID# 224613
LN2 4AX Lincoln
United KingdomRekrutierend» Google-Maps
Guys and St Thomas NHS Foundation Trust /ID# 221041
SE1 9RT London
United KingdomRekrutierend» Google-Maps
James Paget University Hospitals NHS Foundation Trust /ID# 221219
NR31 6LA Great Yarmouth
United KingdomRekrutierend» Google-Maps
University Hospitals Birmingham NHS Foundation Trust /ID# 221334
B15 2TH Birmingham
United KingdomRekrutierend» Google-Maps
NHS Lothian /ID# 224378
EH3 9HE Edinburgh
United KingdomRekrutierend» Google-Maps
The Newcastle Upon Tyne Hospitals NHS Foundation Trust /ID# 221335
NE7 7DN Newcastle upon Tyne
United KingdomRekrutierend» Google-Maps
Alle anzeigen

Studien-Informationen

Brief Summary:

Myelofibrosis (MF) is a rare blood cancer, notable for scarring of the bone marrow (the

spongy tissue inside bones) and the spleen becoming larger. The purpose of this study is to

assess safety and change in spleen volume when navitoclax is given in combination with

ruxolitinib, compared to best available therapy, for adult participants with MF.

Navitoclax is an investigational drug (not yet approved) being developed for the treatment of

MF. Participants in this study will be randomly selected (like picking numbers out of a hat)

to be in 1 of 2 treatment arms. Neither participants nor the study doctor will be able to

pick which treatment arm a participants enters. In Arm A, participants will receive

navitoclax in combination with ruxolitinib. In Arm B, participants will receive the best

available therapy (BAT) for MF. Adult participants with a diagnosis of MF that came back or

did not get better after earlier treatment will be enrolled. Approximately 330 participants

will be enrolled in approximately 210 sites across the world.

In Arm A, participants will receive navitoclax tablet by mouth once daily with by mouth

ruxolitinib tablet twice daily. In Arm B, participants will receive the BAT available to the

investigator. Participants will receive the study drug until they experience no benefit

(determined by the investigator), participants cannot tolerate the study drugs, or

participants withdraw consent. The approximate treatment duration is about 3 years.

There may be higher treatment burden for participants in this trial compared to their

standard of care. Participants will attend regular visits during the study at a hospital or

clinic. The effect of treatment will be checked by medical assessments, blood and bone marrow

tests, checking for side effects, and completing questionnaires.

Ein-/Ausschlusskriterien

Inclusion Criteria:

- Must complete the Myelofibrosis Symptom Assessment Form (MFSAF) v4.0 on at least 4 out

of the 7 days immediately prior to the date of randomization and must agree to collect

MFSAF data daily by ePRO device during the study collection window.

-- Has at least 2 symptoms each with an average score >= 3 or an average total score

of >= 12, as measured by the MFSAF v4.0.

- Documented diagnosis of primary myelofibrosis (MF) as defined by the World Health

Organization (WHO) classification, post polycythemia vera (PPV)-MF, or post essential

thrombocytopenia (PET)-MF, characterized by bone marrow fibrosis grades 2 or 3.

- Classified as intermediate-2 or high-risk MF, as defined by the Dynamic International

Prognostic Scoring System Plus (DIPSS+).

- Must currently be on treatment or have received prior treatment with a single Janus

Kinase 2 (JAK2) inhibitor, ruxolitinib, and meet one of the following criteria (in

addition to the minimum splenomegaly and symptom burden also required for

eligibility):

- Treatment with ruxolitinib for >= 24 weeks that was stopped due to lack of spleen

response (refractory), or loss of spleen response or symptom control after a

previous response (relapsed), or was continued despite relapsed/refractory

status.

- Treatment with ruxolitinib for < 24 weeks with documented disease progression

while on therapy as defined by any of the following:

- Appearance of new splenomegaly that is palpable to at least 5 cm below the

left costal margin (LCM) in participants with no evidence of splenomegaly

prior to the initiation of ruxolitinib.

- A >= 100% increase in the palpable distance below the LCM in participants

with measurable spleen distance 5 to 10 centimeters (cm) prior to the

initiation of ruxolitinib.

- A >= 50% increase in the palpable distance below the LCM in participants

with measurable spleen distance > 10 cm prior to the initiation of

ruxolitinib.

- A spleen volume increase of >= 25% (as assessed by Magnetic Resonance

Imaging [MRI] or Computed Tomography [CT] scan) in participants with a

spleen volume assessment prior to the initiation of ruxolitinib.

- Prior treatment with ruxolitinib of at least 10 mg twice daily (BID) for >= 28

days with intolerance defined as new RBC transfusion requirement (at least 2

units/month for 2 months) while receiving a total daily ruxolitinib dose of >= 30

mg but unable to reduce dose further due to lack of efficacy.

Note: Participant must not require a ruxolitinib dose less than 10 mg BID (20 mg daily) due

to prior history of ruxolitinibrelated ≥ Grade 3 toxicity.

- Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2.

- Splenomegaly defined as palpable spleen measurement >= 5 cm below left costal margin

or spleen volume >= 450 cm3 as assessed centrally by MRI or CT scan.

- Baseline platelet count >= 100 × 10^9/L.

Exclusion Criteria:

- Received prior treatment with a BH3-mimetic compound, bromodomain and extra-terminal

(BET) inhibitor, or prior use of > 1 JAK2 inhibitor or stem cell transplant.

- Eligible for stem cell transplantation at the time of study entry.

- Receiving medication that interferes with coagulation or platelet function within 3

days prior to the first dose of study drug or during the study treatment period except

for low dose aspirin (up to 100 mg daily) and low molecular weight heparin (LMWH).

- Receiving anticancer therapy for an active malignancy or MF including chemotherapy,

radiation therapy, hormonal therapy such that at least 5 half-lives of that medication

is completed at least 7 days prior to the first dose of study drug or within 30 days

prior to first dose of study drug, whichever is shorter, and during the study

treatment period (other than any overlapping therapy as part of the selected BAT).

Studien-Rationale

Primary outcome:

1. Percentage of Participants who achieve Spleen Volume Reduction of at least 35% at Week 24 (SVR35W24) (Time Frame - At Week 24):
Reduction in spleen volume is measured by Magnetic Resonance Imaging (MRI) or Computed Tomography (CT), per International Working Group (IWG) criteria.



Secondary outcome:

1. Percentage of Participants who achieve at least 50% Reduction in Total Symptom Score (TSS) (Time Frame - Baseline (Week 0) Up to Week 24):
Reduction in TSS is measured by Myelofibrosis Symptom Assessment Form (MFSAF) v4.0.

2. Percentage of Participants who achieve Spleen Volume Reduction of at least 35% at any time (Time Frame - Baseline (Week 0) Up to Week 97):
Reduction in spleen volume is measured by Magnetic Resonance Imaging (MRI) or Computed Tomography (CT), per International Working Group (IWG) criteria.

3. Percentage of Participants with Reduction in Grade of Bone Marrow Fibrosis (Time Frame - Baseline (Week 0) Up to Week 97):
Reduction in grade of bone marrow fibrosis from baseline as measured by the European consensus grading system will be assessed.

4. Percentage of Participants with Anemia Response (Time Frame - Baseline (Week 0) Up to Week 97):
Anemia response per International Working Group (IWG) criteria will be assessed.

5. Percentage of Participants with Overall Survival (Time Frame - Last Visit Up to 5 Years):
Overall survival is defined as the time from start of study to the date of death from any cause.

6. Percentage of Participants with Leukemia-free Survival (Time Frame - Last Visit Up to 5 Years):
Leukemia free survival is the time from start of study to the date of development of leukemia.

7. Percentage of Participants with Change in Fatigue (Time Frame - Baseline (Week 0) Up to Week 24):
Change in fatigue will be assessed using the Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue Short Form (SF) 7a.

8. Time to Deterioration of Physical Functioning (Time Frame - Baseline (Week 0) Up to Week 97):
Time to deterioration of physical functioning is measured by the physical functioning domain of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ)-C30, or death.

9. Percentage of Participants with at Least 50% Reduction in TSS (Time Frame - Baseline (Week 0) Up to Week 97):
At least 50% reduction in TSS from baseline (at any time) as measured by MFSAF v4.0.

Studien-Arme

  • Experimental: Arm A: Navitoclax + Ruxolitinib
    Participants will receive navitoclax tablets once daily and ruxolitinib tablets twice daily.
  • Active Comparator: Arm B: Best Available Therapy (BAT)
    Participants will receive one of the BAT options, per the investigator's discretion.

Geprüfte Regime

  • Navitoclax (ABT-263):
    Tablet; Oral
  • Ruxolitinib:
    Tablet; Oral
  • Best Available Therapy (BAT):
    Tablet/Capsule; Oral or Solution for Subcutaneous Injection

Quelle: ClinicalTrials.gov


Sie können folgenden Inhalt einem Kollegen empfehlen:

"Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis"

Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.

Die mit (*) gekennzeichneten Angaben müssen eingetragen werden!

Die Verwendung Ihrer Daten für den Newsletter können Sie jederzeit mit Wirkung für die Zukunft gegenüber der MedtriX GmbH - Geschäftsbereich rs media widersprechen ohne dass Kosten entstehen. Nutzen Sie hierfür etwaige Abmeldelinks im Newsletter oder schreiben Sie eine E-Mail an: rgb-info[at]medtrix.group.